Tumor-infiltrating lymphocytes (TILs) are prognostic factors in HNSCC, their presence correlates with response to immunotherapy, and there is no agreement regarding the correlation between the expression of TILs and that of PD-L1 in HNSCC. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.